怀孕
内科学
子痫前期
临床试验
心脏病
发病机制
作者
Francesca Ziviello,Stefano Conte,Giovanni Cimmino,Ferdinando Carlo Sasso,Bruno Trimarco,Plinio Cirillo
标识
DOI:10.2174/1570161114666161230112126
摘要
Pregnancy-Associated Plasma Protein-A (PAPP-A) is a zinc-binding metalloproteinase protein produced by placental syncytio-trophoblasts and secreted into the maternal circulation where its concentration progressively increases until term. In recent years, PAPP-A has been studied for its potential involvement in cardiovascular (CV) disease. However, all those studies did not provide a clear view to identify the pathophysiological links between PAPP-A plasma levels and the occurrence of CV events. In this review, starting from a complete description of PAPP-A structure and biology, we present an updated overview of experimental as well as clinical evidence on the role of this metalloproteinase in CV disease. Finally, we discuss possible therapeutic approaches to antagonize its potential detrimental CV effects.
科研通智能强力驱动
Strongly Powered by AbleSci AI